Adagene Inc. (FRA:978)
Germany · Delayed Price · Currency is EUR 2.080
+0.020 (0.97%)
Last updated: Oct 23, 2026, 3:25 PM CEST
Adagene Market Cap
Adagene has a market cap or net worth of €144.5 million as of October 26, 2026. Its market cap has increased by 104.60% in one year.
Market Cap
144.50M
Enterprise Value
50.50M
Revenue
8.13M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since February 9, 2021, Adagene's market cap has decreased from 1.05B to 144.50M, a decrease of -86.19%. That is a compound annual growth rate of -29.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 144.50M | 90.46% |
| Dec 31, 2025 | 75.87M | -10.84% |
| Dec 31, 2024 | 85.09M | 11.10% |
| Dec 29, 2023 | 76.59M | 42.27% |
| Dec 30, 2022 | 53.84M | -82.59% |
| Dec 31, 2021 | 309.16M | -70.44% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Stratec SE | 285.66M |
| MEDICLIN Aktiengesellschaft | 249.38M |
| Medios AG | 248.00M |
| LIMES Schlosskliniken AG | 156.42M |